Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026)
Apyx Medical's (APYX) quarterly Cash from Financing Activities came in at $83000.0 in Q1 2026, up 232.0% YoY from $25000.0 in Q1 2025, and down 99.12% on a QoQ basis from $9.5 million in Q4 2025.
Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has 16 years of Cash from Financing Activities data on file, last reported at $83000.0 in Q1 2026.
- Quarterly Cash from Financing Activities rose 232.0% year-over-year to $83000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (up 42.26% YoY) and the FY2025 annual result came in at $9.6 million, up 42.03% from the prior year.
- Cash from Financing Activities declined to $83000.0 in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $23.8 million in Q4 2023 to a low of -$10000.0 in Q4 2022.
- A 5-year average of $2.9 million and a median of $46000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 238540.0% — and 2024, when it plunged 110.87%.
- Tracing APYX's Cash from Financing Activities over 5 years: stood at -$10000.0 in 2022, then soared by 238540.0% to $23.8 million in 2023, then tumbled by 71.65% to $6.8 million in 2024, then soared by 40.31% to $9.5 million in 2025, then slumped by 99.12% to $83000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $83000.0 (Q1 2026), $9.5 million (Q4 2025), and $45000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Apyx Medical | 136.81 Mn | 109.19 Mn | 8.87 Mn | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5,000.00 |
| Jun 30, 2026 | -5,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 9.49 Mn |
| Dec 31, 2025 | 9.49 Mn |
| Sep 30, 2025 | 45,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 6.76 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |